- Role
- Country
- Date of registration
- Address
US-MF-000024901C1qScreen Class I Positive Control is an EU IVDR-regulated in vitro diagnostic registered in EUDAMED. It is classified as IVDR Class C. Manufactured by One Lambda, Inc.. Placed on the EU market in Austria. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on May 18, 2026
081211701C1Q5JPrimary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
(01)00812117017853
The compliance carrier: encodes the device identifier plus the production identifiers (lot, serial, dates) registered for this device.
4 warnings recorded — scroll inside the panel to see all entries.
CW074CW103CW104CW011Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Primary placement in Austria; available across 32 countries total.
| Country | On market since | Until |
|---|---|---|
| AustriaPrimary placement | Nov 29, 2013 | Still on market |
| Belgium | Nov 29, 2013 | Still on market |
| Bulgaria | Nov 29, 2013 | Still on market |
| Cyprus | Nov 29, 2013 | Still on market |
| Czechia | Nov 29, 2013 | Still on market |
| Germany | Nov 29, 2013 | Still on market |
| Denmark | Nov 29, 2013 | Still on market |
| Estonia | Nov 29, 2013 | Still on market |
| EL | Nov 29, 2013 | Still on market |
| Spain | Nov 29, 2013 | Still on market |
| Finland | Nov 29, 2013 | Still on market |
| France | Nov 29, 2013 | Still on market |
| Croatia | Nov 29, 2013 | Still on market |
| Hungary | Nov 29, 2013 | Still on market |
| Ireland | Nov 29, 2013 | Still on market |
| Iceland | Nov 29, 2013 | Still on market |
| Italy | Nov 29, 2013 | Still on market |
| Liechtenstein | Nov 29, 2013 | Still on market |
| Lithuania | Nov 29, 2013 | Still on market |
| Luxembourg | Nov 29, 2013 | Still on market |
| Latvia | Nov 29, 2013 | Still on market |
| Malta | Nov 29, 2013 | Still on market |
| Netherlands | Nov 29, 2013 | Still on market |
| Norway | Nov 29, 2013 | Still on market |
| Poland | Nov 29, 2013 | Still on market |
| Portugal | Nov 29, 2013 | Still on market |
| Romania | Nov 29, 2013 | Still on market |
| Sweden | Nov 29, 2013 | Still on market |
| Slovenia | Nov 29, 2013 | Still on market |
| Slovakia | Nov 29, 2013 | Still on market |
| Türkiye | Nov 29, 2013 | Still on market |
| XI | Nov 29, 2013 | Still on market |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
00812117017853Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
081211701C1Q5JC1QS-PC1UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W01030402HLA ANTIBODY SCREENINGNo certificate specifically references this device's Basic UDI-DI.
Certificate health across this manufacturer's portfolio.
HX 2233216-1IssuedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →